Epidemiology of men with synchronous metastatic prostate cancer diagnosis - A nationwide 26-year temporal analysis

Keyphrases

• Epidemiology 100%
• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 100%
• Prostate Cancer Screening 100%
• Temporal Analysis 100%
• Denmark 33%
• Prostate Cancer Risk 33%
• Median Survival 33%
• Delayed Diagnosis 16%
• Median Time 16%
• Clinical Trials 16%
• Working Diagnosis 16%
• Treatment Trials 16%
• Enhanced Awareness 16%
• Prostate Cancer 16%
• Androgen Deprivation Therapy 16%
• Imaging Modalities 16%
• Improved Survival 16%
• Novel Therapies 16%
• Median Overall Survival 16%
• Prolonged Survival 16%
• Tailored Treatment 16%
• Time Since Death 16%
• Kaplan-Meier Method 16%
• Prostate-specific Antigen Testing 16%
• Aalen-Johansen Estimator 16%
• Prolonged Life 16%
• Trends in Survival 16%

Medicine and Dentistry

• Cohort Effect 100%
• Prostate Cancer 100%
• Prostate Cancer Diagnosis 100%
• Temporal Analysis 100%
• Awareness 12%
• Clinical Trial 12%
• Androgen 12%
• Cancer Mortality 12%
• Prostate Specific Antigen 12%
• Overall Survival 12%
• Kaplan Meier Method 12%